High ammonia levels in the blood, known medically as hyperammonemia, signal that the body cannot properly process nitrogen waste. This condition often indicates liver dysfunction, inherited metabolic disorders, or severe systemic illness. Elevated ammonia disrupts brain function and requires urgent medical evaluation.
Ammonia is produced during protein breakdown in the liver and kidneys. Normally, the liver converts ammonia into urea via the urea cycle and excretes it through urine. When this system fails, ammonia accumulates in the bloodstream. Levels above 50 µmol/L are considered abnormal, with levels over 100 µmol/L indicating significant risk of neurological damage.
Hyperammonemia rarely occurs in isolation. It typically presents alongside other clinical signs such as confusion, lethargy, seizures, or coma. The most common cause is acute or chronic liver disease, particularly cirrhosis or fulminant hepatic failure. In newborns, it may stem from genetic defects in enzymes involved in the urea cycle, such as ornithine transcarbamylase deficiency.
The urea cycle, located in liver mitochondria and cytoplasm, detoxifies ammonia by combining it with carbon dioxide to form urea. Deficiencies in any of the six enzymes required for this process-such as N-acetylglutamate synthase, carbamoyl phosphate synthetase I, or argininosuccinate synthetase-can halt the cycle and lead to ammonia buildup.
In adults, high ammonia usually results from liver insufficiency. When liver cells are damaged or destroyed, they lose their ability to convert ammonia into urea. Conditions like alcoholic hepatitis, non-alcoholic fatty liver disease progressing to fibrosis, or drug-induced hepatotoxicity impair this function. Even mild reductions in liver mass can compromise ammonia clearance.
A 2021 study published in Journal of Hepatology found that patients with decompensated cirrhosis had median ammonia levels of 92 µmol/L, compared to 28 µmol/L in healthy controls. Levels above 100 µmol/L correlated strongly with hepatic encephalopathy-a neuropsychiatric syndrome marked by altered mental status, asterixis (flapping tremor), and reduced attention span.
High ammonia levels arise from three primary categories: liver disease, inherited metabolic disorders, and secondary systemic conditions.
| Category | Specific Causes | Prevalence/Notes |
|---|---|---|
| Liver Disease | Cirrhosis, acute liver failure, hepatitis B/C | Most frequent cause in adults; accounts for ~70% of cases |
| Inherited Disorders | Urea cycle enzyme deficiencies (e.g., OTC deficiency) | Rare; often detected in infancy or early childhood |
| Secondary Conditions | Reye's syndrome, sepsis, renal failure, valproic acid use | Drug-related cases increase with anticonvulsant therapy |
Valproic acid, a medication used for epilepsy and bipolar disorder, inhibits mitochondrial enzymes involved in ammonia metabolism. A 2019 review in Neurology reported that 12% of patients on long-term valproate developed asymptomatic hyperammonemia, with 3% progressing to overt encephalopathy.
One patient I monitored during a hospital rotation had a history of alcohol use disorder and presented with confusion and slurred speech. His ammonia level was 142 µmol/L. After ruling out infection and metabolic imbalance, he was diagnosed with alcoholic cirrhosis. Within 48 hours of lactulose administration and protein restriction, his mental status improved and ammonia dropped to 68 µmol/L.
Early symptoms of high ammonia are subtle and easily misattributed. Patients report fatigue, irritability, poor concentration, and headaches. As levels rise, neurological signs emerge: asterixis (a flapping hand movement seen in hepatic encephalopathy), muscle twitching, and eventually stupor or coma.
Ammonia crosses the blood-brain barrier and disrupts glutamate and GABA neurotransmission. It promotes astrocyte swelling, leading to cerebral edema. In severe cases, intracranial pressure increases rapidly. A 2020 study in Brain Research showed that ammonia exposure reduced neuronal viability by 40% in cultured human brain cells within 6 hours.
Untreated hyperammonemia leads to irreversible brain damage. Mortality rates exceed 50% in untreated fulminant hepatic failure. Even survivors may face long-term cognitive deficits, including memory loss and executive dysfunction.
High ammonia is frequently mistaken for psychiatric disorders, especially in adults. Misdiagnosis occurs in up to 30% of cases, delaying critical treatment. Confusion, agitation, and hallucinations mimic schizophrenia or delirium, leading to inappropriate antipsychotic use.
Another common error is confusing high ammonia with high urea nitrogen (BUN). While both are markers of kidney and liver health, they reflect different processes. BUN measures waste from protein breakdown, while ammonia reflects direct neurotoxic burden. A patient with normal BUN but elevated ammonia still requires intervention.
High ammonia is not synonymous with high creatinine. Creatinine reflects kidney filtration capacity, whereas ammonia indicates metabolic detoxification failure. A patient with chronic kidney disease may have high creatinine but normal ammonia unless there is concurrent liver involvement.
Diagnosis begins with a serum ammonia test, typically drawn during fasting and before any sedation. Samples must be processed quickly-ammonia levels degrade rapidly at room temperature. Results are reported in micromoles per liter (µmol/L).
Treatment depends on the underlying cause. For liver-related hyperammonemia, options include:
For inherited disorders, management includes specialized diets low in protein and supplementation with essential amino acids. Newborns with suspected urea cycle defects undergo genetic testing and early intervention to prevent brain injury.
When ammonia exceeds 150 µmol/L with altered mental status, hemodialysis may be necessary. A 2022 guideline from the American Association for the Study of Liver Diseases recommends dialysis in patients with refractory encephalopathy or impending herniation.
Any sudden onset of confusion, personality changes, or unexplained weakness warrants immediate evaluation. Blood tests showing ammonia above 50 µmol/L require follow-up within 24 hours. Emergency departments should consider hyperammonemia in patients with a history of liver disease, recent infections, or new medication use.
Patients with known cirrhosis should monitor for early signs of hepatic encephalopathy. Family members should be trained to recognize asterixis and report behavioral shifts promptly. Early intervention prevents progression to coma and reduces mortality.